Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression

Wan Li Cheng, Ming Chieh Tsai, Chung Ying Tsai, Ya Hui Huang, Cheng Yi Chen, Hsiang Cheng Chi, Yi Hsin Tseng, Im Wai Chao, Chi Wei Lin, Sheng Ming Wu, Ying Liang, Chia Jung Liao, Yang Hsiang Lin, I. Hsiao Chung, Wei Jan Chen, Paul Yann Lin, Chia Siu Wang, Kwang Huei Lin

研究成果: 雜誌貢獻文章同行評審

45 引文 斯高帕斯(Scopus)


Glyoxalase I (GLO1), a methylglyoxal detoxification enzyme, is implicated in the progression of human malignancies. The role of GLO1 in gastric cancer development or progression is currently unclear. The expression of GLO1 was determined in primary gastric cancer specimens using quantitative polymerase chain reaction, immunohistochemistry (IHC), and western blotting analyses. GLO1 expression was higher in gastric cancer tissues, compared with that in adjacent noncancerous tissues. Elevated expression of GLO1 was significantly associated with gastric wall invasion, lymph node metastasis, and pathological stage, suggesting a novel role of GLO1 in gastric cancer development and progression. The 5-year survival rate of the lower GLO1 expression groups was significantly greater than that of the higher expression groups (log rank P = 0.0373) in IHC experiments. Over-expression of GLO1 in gastric cancer cell lines increases cell proliferation, migration and invasiveness. Conversely, down-regulation of GLO1 with shRNA led to a marked reduction in the migration and invasion abilities. Our data strongly suggest that high expression of GLO1 in gastric cancer enhances the metastasis ability of tumor cells in vitro and in vivo, and support its efficacy as a potential marker for the detection and prognosis of gastric cancer.
期刊PLoS One
出版狀態已發佈 - 3月 29 2012

ASJC Scopus subject areas

  • 農業與生物科學 (全部)
  • 生物化學、遺傳與分子生物學 (全部)
  • 醫藥 (全部)


深入研究「Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression」主題。共同形成了獨特的指紋。